Indiana University School of Medicine researcher Jeff Dage’s years of research into biomarkers helped lead to a ...

Bill Gates is speaking out about his personal experience with Alzheimer’s — and his hope for progress in fighting the disease ...

A newly approved Alzheimer’s drug is set to be administered for the first time in Taiwan on Monday, Far Eastern Memorial Hospital in New Taipei City announced yesterday. Kisunla, the brand name of the ...

In a first for the bloc, Europe’s Committee for Medicinal Products for Human Use (CHMP) has recommended marketing ...

And other biotech news brought to you by The Readout.

NEW YORK – The UK's National Institute for Health and Care Excellence on Thursday issued two final guidances, in which it recommended against making Eisai and Biogen's Leqembi (lecanemab) and Eli ...

A routine medical appointment revealed the first sign of early-onset dementia for Jim Rogers, a 58-year-old British man ...

LLY's blockbuster obesity drugs fuel rapid growth but ABBV's valuation and pipeline may offer safer short-term upside.

And more pharma news updates from Pharmalittle.

Jim Rogers, 58, was living and working in Australia when he started to develop symptoms of the incurable neurological ...

Microsoft co-founder Bill Gates reflects on his father's Alzheimer's battle and expresses optimism about advancements in ...

Eli Lilly (NYSE:LLY) announced it would appeal a decision by the U.K. health authorities not to recommend the company’s new ...